849067-95-4

Basic information

• Product Name: 1H-Pyrrolo[2,3-b]pyridine-5-carboxylic acid, 1-[(4-methylphenyl)sulfonyl]-, methyl ester
• Synonyms: 1H-Pyrrolo[2,3-b]pyridine-5-carboxylic acid, 1-[(4-methylphenyl)sulfonyl]-, methyl ester;AFJWRJSEKOVVFH-UHFFFAOYSA-N
• CAS NO: 849067-95-4
• Molecular Formula: C₁₆H₁₄N₂O₄S
• Molecular Weight: 330.36
• Mol File: 849067-95-4.mol

Chemical Properties

• Boiling Point: 508.3°C at 760 mmHg
• Flash Point: 261.2°C
• Appearance: /
• Density: 1.36g/cm³
• Vapor Pressure: 1.88E-10mmHg at 25°C
• Refractive Index: 1.639
• CAS DataBase Reference: 1H-Pyrrolo[2,3-b]pyridine-5-carboxylic acid, 1-[(4-methylphenyl)sulfonyl]-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Pyrrolo[2,3-b]pyridine-5-carboxylic acid, 1-[(4-methylphenyl)sulfonyl]-, methyl ester(849067-95-4)
• EPA Substance Registry System: 1H-Pyrrolo[2,3-b]pyridine-5-carboxylic acid, 1-[(4-methylphenyl)sulfonyl]-, methyl ester(849067-95-4)

Safety Data

• Hazardous Substances Data: 849067-95-4(Hazardous Substances Data)

Usage

Molecular Structure

1H-Pyrrolo[2,3-b]pyridine-5-carboxylic acid, 1-[(4-methylphenyl)sulfonyl]-, methyl ester has a complex molecular structure, consisting of a pyrrolopyridine core with additional functional groups.

Ester Derivative

It is an ester derivative of pyrrolopyridine-carboxylic acid, indicating the presence of an ester functional group (R-COO-R') in the molecule.

Methyl Ester Group

The compound has a methyl ester group (-COOCH3) attached to the carboxylic acid, which influences its reactivity and properties.

Pharmaceutical Applications

The compound is often used in the pharmaceutical industry for the development of new drugs, due to its unique structure and functional groups.

Organic Synthesis Building Block

It serves as a potential building block for organic synthesis, making it a versatile compound for creating more complex molecules.

Versatility

The compound has potential applications in various chemical and medical fields, thanks to its unique structure and functional groups.

InChI:InChI=1/C16H14N2O4S/c1-11-3-5-14(6-4-11)23(20,21)18-8-7-12-9-13(16(19)22-2)10-17-15(12)18/h3-10H,1-2H3

Upstream product

• 67-56-1 methanol 
• 479552-71-1 5-bromo-1-(p-tolylsulfonyl)pyrrolo[2,3-b]pyridine 
• 201230-82-2 carbon monoxide 
• 849067-96-5 1H-pyrrolo[2,3-b]pyridine-5-carboxylic acid methyl ester 
• 98-59-9 p-toluenesulfonyl chloride 

Downstream Products

• 849067-96-5 1H-pyrrolo[2,3-b]pyridine-5-carboxylic acid methyl ester 

Relevant articles and documents

cGAS ANTAGONIST COMPOUNDS

Disclosed are novel compounds of Formula (I) that are cGAS antagonists, methods of preparation of the compounds, pharmaceutical compositions comprising the compounds, and their use in medical therapy.

COMPOSITIONS USEFUL AS INHIBITORS OF PROTEIN KINASES

The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.